NCT04024826

Brief Summary

This research project's objective is to investigate substrate metabolism behavior in response to the RT during different phases of the menstrual cycle.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 18, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 16, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 16, 2020

Completed
Last Updated

October 4, 2021

Status Verified

July 1, 2019

Enrollment Period

9 months

First QC Date

March 21, 2019

Last Update Submit

September 27, 2021

Conditions

Keywords

resistance trainingcarbohydrate metabolismfat oxidation

Outcome Measures

Primary Outcomes (3)

  • Changes in Substrate oxidation

    changes in substrate oxidation will be measured using cosmed K5 during the intervention phase

    During each exercise session: 1 assessment point on each menstrual cycle phase

  • Changes in Estrogen levels.

    Blood would be drawn from the participants for assessment of hormone estrogen

    At baseline: 1 assessment point on each menstrual cycle phase

  • Changes in Progesterone levels.

    Blood would be drawn from the participants for assessment of hormone Progesterone.

    At baseline: 1 assessment point on each menstrual cycle phase

Secondary Outcomes (6)

  • Muscular strength

    At baseline: 1 assessment point

  • Cardiorespiratory Function

    At baseline: 1 assessment point

  • Relative Body Fat (%)

    At baseline: 1 assessment point

  • Lean Body Mass (kg)

    At baseline: 1 assessment point

  • Fat Mass (kg)

    At baseline: 1 assessment point

  • +1 more secondary outcomes

Study Arms (4)

Early Follicular Phase (EFP)

EXPERIMENTAL

This group is comprised of participants at the Early Follicular Phase (EFP) of the menstrual cycle.

Behavioral: EFP

Late Follicular Phase

EXPERIMENTAL

This group is comprised of participants at the Late Follicular Phase (LFP) of the menstrual cycle.

Behavioral: LFP

Early Luteal Phase

EXPERIMENTAL

This group is comprised of participants at the Early Luteal Phase (ELP) of the menstrual cycle.

Behavioral: ELP

Late Luteal Phase

EXPERIMENTAL

This group is comprised of participants at the Late Luteal Phase(LLP) of the menstrual cycle.

Behavioral: LLP

Interventions

EFPBEHAVIORAL

This group will perform the Resistance training intervention on day 4 of the menstrual cycle, which corresponds to the mid of early follicular phase.

Early Follicular Phase (EFP)
LFPBEHAVIORAL

This group will perform the Resistance training intervention on day 11 of the menstrual cycle, which corresponds to the mid of late follicular phase.

Late Follicular Phase
ELPBEHAVIORAL

This group will perform the Resistance training intervention on the day 18 of the menstrual cycle, which corresponds to the mid of early luteal phase

Early Luteal Phase
LLPBEHAVIORAL

This group will perform the Resistance training intervention on day 21 of the menstrual cycle, which corresponds to the mid of late luteal phase

Late Luteal Phase

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales with a normal menstrual cycle defined as 28-30 days and a duration of 3-7 days with BMI-18.5-34.99 and between 18-45 years.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Females with BMI-18.5-34.99 and between 18-45 years, with normal menstrual cycle defined as 28-30 days cycles +-3 days.
  • Including higher BMI participants might alter the results as increased body fat has been linked to changes in different hormonal levels (not only sex hormones) and that might influence substrate utilization.
  • Sedentary .or physically active for 2 days a week or less.

You may not qualify if:

  • Musculoskeletal injuries,
  • cardio-respiratory conditions,
  • metabolic conditions,
  • irregular menstrual cycle,
  • menstrual dysfunction or unusual sex hormone levels,
  • on contraceptives,
  • on medication that alter hormonal or cardio-respiratory responses,
  • pre-menopausal symptoms,
  • on moderate to high-intensity exercise regime more than 2d/week.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southern Illinois University Edwardsville

Edwardsville, Illinois, 62026, United States

Location

Study Officials

  • Maria Fernandez del Valle, PhD

    Southern Illinois University Edwardsville

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: The participants will be randomized into either one of the 4 four phases- namely Early Follicular Phase(EFP-Days1 to 7), Late Follicular Phase(LFP-Days 8 to 14), Early Luteal Phase(ELP-Days 15 to 21) or Late Luteal Phase(LLP-Days 22 to 28) of the menstrual phase. Once the participant is assigned to one of the phases. Each participant will undergo 4 intervention days. the first intervention day will take place during the mid-point of the said phase i.e. EFP- Day 4. After one intervention is complete there will be a washout period and the intervention will take place on the 7th day after the first intervention i.e if the first intervention is LFP done on day 11 of the menstrual cycle the next intervention will take place on day 18 of menstrual cycle which will account for ELP. In this manner, the Participant will be tested in all 4 phases.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2019

First Posted

July 18, 2019

Study Start

July 1, 2019

Primary Completion

March 16, 2020

Study Completion

March 16, 2020

Last Updated

October 4, 2021

Record last verified: 2019-07

Locations